Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Nantes Cedex 1, France
  • +19 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +117 more
Aug 3, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +67 more
Jul 26, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +34 more
Jul 22, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone Trial in Worldwide (HPN217)

Recruiting
  • Multiple Myeloma in Relapse
  • +3 more
  • Gilbert, Arizona
  • +17 more
Jul 21, 2022

Multiple Myeloma Trial in Worldwide (bb2121)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • San Francisco, California
  • +47 more
Jul 18, 2022

Multiple Myeloma Trial in Worldwide (CTX120)

Active, not recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
Jul 14, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Whittier, California
  • +19 more
Feb 2, 2022

Multiple Myeloma Trial in Worldwide (CC-92328)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +16 more
Feb 4, 2022

Multiple Myeloma Trial in Spain (Clarithromycin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • A Coruña, Spain
  • +25 more
Jan 17, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Graz, Austria
  • +111 more
Dec 10, 2021

Multiple Myeloma Trial in Spain (Belantamab mafodotin, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +4 more
  • Sevilla, Andalucia, Spain
  • +17 more
Dec 3, 2021

Multiple Myeloma Trial in Würzburg, Pamplona (SLAMF7 CAR-T)

Recruiting
  • Multiple Myeloma
  • SLAMF7 CAR-T
  • Würzburg, Germany
  • +1 more
Oct 5, 2021